NEWOD CV, combining Cefpodoxime 200 mg and Clavulanic Acid 125 mg, is a powerful oral antibiotic providing broad-spectrum coverage against both Gram-positive and Gram-negative bacteria. Its efficacy is comparable to that of parental cephalosporins, making it a reliable choice for treating various infections, including sinusitis, pharyngitis, tonsillitis, acute otitis media, pneumonia, bronchitis, skin and soft tissue infections, and urinary tract infections. With better safety and tolerability, NEWOD CV is suitable for use across all age groups, ensuring effective and stable treatment outcomes.